# Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )

> **NCT07390604** · — · COMPLETED · sponsor: **Centre Hospitalier Régional Metz-Thionville** · enrollment: 5 (actual)

## Conditions studied

- Lipoprotein(a)
- Lipoprotein-apheresis
- Double-filtration Plasmapheresis
- Hemodialysis Complication
- End Stage Chronic Renal Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07390604
- **Lead sponsor:** Centre Hospitalier Régional Metz-Thionville
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07390604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07390604, "Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07390604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*